Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Golden Leaf GLH or GLDFf -- Ignore unavailable to you. Want to Upgrade?

To: ayeyou who wrote (877)	10/5/2016 6:43:48 PM
From: Rocket Red	Read Replies (1) \| Respond to of 1211

oh well i'm making dollars and that write was most likely long ago and the Canadian weeds are rolling big time triple already

To: ayeyou who wrote (877)	10/5/2016 6:47:58 PM
From: Rocket Red	Respond to of 1211

another version Chris Parry Quote "Abattis is my vertical integration play of choice, as they have so many moving parts, you almost feel like at least one of those has to pop as a genuine profitmaker. Between Biocube Grow Systems, Phytalab, iJuana Cannabis, Experion Technologies, Biocell Labs, Instant Payment Systems, North American BioExtracts and Northern Vine, the catch for Abattis will be getting all the parts to work well together and not just bleed capital. That said, they’ve got plenty of assets that can be flipped for cash when and if needed. I’ve touted them as a legitimacy play for a long time and I’m sensing activity on the horizon. Time to watch hard."